Diabetes and incident heart failure in hypertensive and normotensive participants of the Strong Heart Study

Journal of Hypertension

Volumn 28, Issue 2, 2010, Pages 353-360

  De Simone, Giovanni ^a,b   Devereux, Richard B ^a   Chinali, Marcello ^b   Lee, Elisa T ^c   Galloway, James M ^d   Barac, Ana ^e   Panza, Julio A ^e   Howard, Barbara V ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e MEDSTAR RESEARCH INSTITUTE   (United States)

Author keywords

Cardiovascular risk; Hypertension; Myocardial infarction; Obesity; Risk factors

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE DISTRIBUTION; ALBUMIN URINE LEVEL; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT DISTRIBUTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; EDUCATIONAL STATUS; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; HYPOTHESIS; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; URINE LEVEL;

EID: 75149129609     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3283331169     Document Type: Article

References (48)

1. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251-259.
2. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52:1210-1214.
3. Howard BV, Lee ET, Cowan LD, Fabsitz RR, Howard WJ, Oopik AJ, et al. Coronary heart disease prevalence and its relation to risk factors in American Indians. The Strong Heart Study. Am J Epidemiol 1995; 142:254-268.
4. Lee ET, Fabsitz R, Cowan LD, Le NA, Oopik AJ, Cucchiara AJ, et al. The Strong Heart Study: a study of cardiovascular disease in American Indians: design and methods. Am J Epidemiol 1990; 136:1141-1155.
5. Howard BV, Lee ET, Cowan LD, Devereux RB, Galloway JM, Go OT, et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. Circulation 1999; 99:2389-2395.
6. Yurgalevitch SM, Kriska AM, Welty TK, Go O, Robbins DC, Howard BV. Physical activity and lipids and lipoproteins in American Indians ages 45-74. Med Sci Sports Exerc 1998; 30:543-549.
7. Schulz LO, Harper IT, Smith CJ, Kriska AM, Ravussin E. Energy intake and physical activity in Pima Indians: comparison with energy expenditure measured by doubly-labeled water. Obes Res 1994; 2:541-548.
8. Kriska AM, Knowler WC, LaPorte RE, Drash AL, Wing RR, Blair SN, et al. Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians. Diabetes Care 1990; 13:401-411.
9. Lu W, Jablonski KA, Resnick HE, Jain AK, Jones KL, Gottlieb AM, et al. Alcohol intake and glycemia in American Indians: the Strong Heart Study. Metabolism 2003; 52:129-135.
10. Satagopan JM, Ben Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004; 91:1229-1235.
11. Mayer J. Uber den Zusammenhang des Diabetes Mellitus mit Erkrankungen des Herzens. Zeitschr Klin Med 1888; 14:212-239.
12. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972; 30:595-602.
13. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974; 34:29-34.
14. Regan TJ, Lyons MM, Ahmed SS, Levinson GE, Oldewurtel HA, Ahmad MR, Haider B. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 1977; 60:884-899.
15. Sanderson JE, Brown DJ, Rivellese A, Kohner E. Diabetic cardiomyopathy? An echocardiographic study of young diabetics. BMJ 1978; 1:404-407.
16. Liu JE, Robbins DC, Palmieri V, Bella JN, Roman MJ, Fabsitz R, et al. Association of albuminuria with systolic and diastolic left ventricular dysfunction in type 2 diabetes: the Strong Heart Study. J Am Coll Cardiol 2003; 41:2022-2028. (Pubitemid 36677126)
17. Coughlin SS, Pearle DL, Baughman KL, Wasserman A, Tefft MC. Diabetes mellitus and risk of idiopathic dilated cardiomyopathy. The Washington, DC Dilated Cardiomyopathy Study. Ann Epidemiol 1994; 4:67-74.
18. Zannad F, Briancon S, Juilliere Y, Mertes PM, Villemot JP, Alla F, Virion JM. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL Study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol 1999; 33:734-742.
19. Aronow WS, Ahn C. Incidence of heart failure in 2737 older persons with and without diabetes mellitus. Chest 1999; 115:867-868.
20. Gottdiener JS, Arnold AM, Aurigemma GP, Polak JF, Tracy RP, Kitzman DW, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35:1628-1637.
21. Nichols GA, Hillier TA, Erbey JR, Brown JB. Congestive heart failure in type 2 diabetes: prevalence, incidence, and risk factors. Diabetes Care 2001; 24:1614-1619.
22. Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV. Glycemic control and heart failure among adult patients with diabetes. Circulation 2001; 103:2668-2673.
23. Ingelsson E, Sundstrom J, Arnlov J, Zethelius B, Lind L. Insulin resistance and risk of congestive heart failure. JAMA 2005; 294:334-341. (Pubitemid 41043777)
24. Thrainsdottir IS, Aspelund T, Thorgeirsson G, Gudnason V, Hardarson T, Malmberg K, et al. The association between glucose abnormalities and heart failure in the population-based Reykjavik study. Diabetes Care 2005; 28:612-616. (Pubitemid 40315321)
25. Butler J, Rodondi N, Zhu Y, Figaro K, Fazio S, Vaughan DE, et al. Metabolic syndrome and the risk of cardiovascular disease in older adults. J Am Coll Cardiol 2006; 47:1595-1602.
26. Held C, Gerstein HC, Yusuf S, Zhao F, Hilbrich L, Anderson C, et al. Glucose levels predict hospitalization for congestive heart failure in patients at high cardiovascular risk. Circulation 2007; 115:1371-1375. (Pubitemid 46648372)
27. von Lewinski D, Bruns S, Walther S, Kogler H, Pieske B. Insulin causes [Ca2\+]i-dependent and [Ca2\+]i-independent positive inotropic effects in failing human myocardium. Circulation 2005; 111:2588-2595.
28. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: part I: general concepts. Circulation 2002; 105:1727-1733. (Pubitemid 34298619)
29. Young ME, McNulty P, Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms. Circulation 2002; 105:1861-1870. (Pubitemid 34408899)
30. Valensi P, Sachs RN, Lormeau B, Taupin JM, Ouzan J, Blasco A, et al. Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 1997; 23:409-416.
31. Goraya TY, Leibson CL, Palumbo PJ, Weston SA, Killian JM, Pfeifer EA, et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. J Am Coll Cardiol 2002; 40:946-953.
32. Galderisi M, Anderson KM, Wilson PW, Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 1991; 68:85-89.
33. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Lee ET, Welty TK, et al. Impact of diabetes on cardiac structure and function: the Strong Heart Study. Circulation 2000; 101:2271-2276.
34. Inoue T, Fujito T, Asahi S, Hoshi K, Sakai Y, Morooka S. Impaired left ventricular diastolic filling occurs in diabetic patients without atherosclerotic coronary artery disease. Am J Med Sci 1997; 313:125-130.
35. Guglielmi MD, Pierdomenico SD, Salvatore L, Romano F, Tascione E, Pupillo M, et al. Impaired left ventricular diastolic function and vascular postischemic vasodilation associated with microalbuminuria in IDDM patients. Diabetes Care 1995; 18:353-360.
36. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well controlled type 2 diabetes mellitus. Am J Cardiol 2001; 87:320-323.
37. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001; 24:5-10.
38. Cosson S, Kevorkian JP, Virally ML, Henry P, Laloi-Michelin M, Meas T, et al. No evidence for left ventricular diastolic dysfunction in asymptomatic normotensive type 2 diabetic patients: a case-control study with new echocardiographic techniques. Diabetes Metab 2007; 33:61-67.
39. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ, et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42:328-335.
40. An D, Rodrigues B. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2006; 291:H1489-H1506.
41. Abe T, Ohga Y, Tabayashi N, Kobayashi S, Sakata S, Misawa H, et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol 2002; 282:H138-H148.
42. Guha A, Harmancey R, Taegtmeyer H. Nonischemic heart failure in diabetes mellitus. Curr Opin Cardiol 2008; 23:241-248.
43. Galderisi M, de Simone G, Cicala S, De Simone L, D'Errico A, Caso P, de Divitiis O. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 2003; 21:2183-2188.
44. de Simone G, Devereux RB, Chinali M, Lee ET, Galloway JM, Howard BV. Cardiovascular phenotype predicting incident heart failure in diabetes: The Strong Heart Study (abstract). J Am Coll Cardiol 2008; 51 (Suppl A):A359.
45. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555.
46. Gregg EW, Cheng YJ, Narayan KM, Thompson TJ, Williamson DF. The relative contributions of different levels of overweight and obesity to the increased prevalence of diabetes in the United States: 1976-2004. Prev Med 2007; 45:348-352.
47. British Heart Foundation. Overall prevalence of diabetes. Statistical website, editor. 12-19-2008. http://www.heartstats.org/ datapage.asp?id=1106.
48. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care 2001; 24:1936-1940.